☆ 4.7 Article

Increased TIM-3 and galectin-9 serum levels in patients with advanced systemic mastocytosis

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Hematology

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Daniel A. Arber et al.

Summary: In 2016, the WHO, Society for Hematopathology, and European Association for Haematopathology collaborated to update the classification of myeloid neoplasms and acute leukemias, advancing the field of myeloid neoplasms and acute leukemias.

BLOOD (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial

Jason Gotlib et al.

Summary: The study evaluated the efficacy of avapritinib in patients with AdvSM and demonstrated high rates of clinical, morphological, and molecular responses with good tolerability.

NATURE MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial

Daniel J. DeAngelo et al.

Summary: The study evaluated the efficacy and safety of avapritinib in patients with AdvSM. Results showed that avapritinib induced deep and durable responses in patients at the recommended dose, demonstrating good tolerability.

NATURE MEDICINE (2021)

添加到收藏夹

Review Oncology

Next generation of immune checkpoint inhibitors and beyond

Julian A. Marin-Acevedo et al.

Summary: The immune system plays a crucial role in defending against cancer, but tumor cells can evade immune recognition. Immunotherapy enhances host immune response to combat tumors.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

添加到收藏夹

Article Hematology

Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal

Peter Valent et al.

Summary: Mastocytosis is a hematologic neoplasm characterized by the expansion and accumulation of neoplastic mast cells in various organs. Recent developments necessitate updates and refinements in the classification and diagnostic criteria of MC neoplasms. Adjustments in the classification of CM and SM, refinements in diagnostic criteria of SM variants, and updated criteria for MCAS were proposed for better diagnostic evaluation and prognostication.

HEMASPHERE (2021)

添加到收藏夹

Article Hematology

Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosis

Georg Greiner et al.

HAEMATOLOGICA (2020)

添加到收藏夹

Article Allergy

Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis

Karin Hartmann et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

添加到收藏夹

Review Medicine, Research & Experimental

Immune escape and immunotherapy of acute myeloid leukemia

Luca Vago et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

添加到收藏夹

Review Hematology

Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts

Peter Valent et al.

BLOOD (2017)

添加到收藏夹

Article Allergy

Risk Factor Analysis of Anaphylactic Reactions in Patients With Systemic Mastocytosis

Theo Gulen et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)

添加到收藏夹

Letter Allergy

Expression of programmed cell death ligand-1 in mastocytosis correlates with disease severity

Anja Rabenhorst et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)

添加到收藏夹

Article Allergy

Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology

Karin Hartmann et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)

添加到收藏夹

Article Medicine, General & Internal

Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis

Jason Gotlib et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

添加到收藏夹

Article Hematology

Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis

Thomas Kristensen et al.

AMERICAN JOURNAL OF HEMATOLOGY (2014)

添加到收藏夹

Article Hematology

The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis

Philipp Erben et al.

ANNALS OF HEMATOLOGY (2014)

添加到收藏夹

Article Hematology

TIM-1 and TIM-3 enhancement of Th2 cytokine poduction by mast cells

Susumu Nakae et al.

BLOOD (2007)

添加到收藏夹

Article Dermatology

TIM-3 is expressed in melanoma cells and is upregulated in TGF-beta stimulated mast cells

Zoltan Wiener et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)

添加到收藏夹

Article Allergy

Serum tryptase levels in patients with mastocytosis: Correlation with mast cell burden and implication for defining the category of disease

WR Sperr et al.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2002)

添加到收藏夹

Article Oncology

Diagnostic criteria and classification of mastocytosis:: a consensus proposal

P Valent et al.

LEUKEMIA RESEARCH (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.